FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...
Abrocitinib can help achieve minimal disease activity in patients with atopic dermatitis irrespective of previous exposure to ...
LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab ...
Investor's Business Daily on MSN
Biotech stock Arcutis climbs into buy zone as FDA mulls expanded use for key skin treatment
Biotech stock Arcutis is in a buy zone and Wall Street is looking for the skin-diseases drugmaker to expand the use of its ...
Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...
Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear ...
Add Yahoo as a preferred source to see more of our stories on Google. Considered in the past to be primarily a children's condition, atopic dermatitis can affect people of all ages If you’re over 60 ...
Diagnosis and management of atopic dermatitis, a type of eczema, are complicated by skin temperature fluctuations, unclear ...
Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies ...
Flaky scalp, itchiness and painful patches can all be signs of scalp dermatitis, an inflammation of the scalp that can have as many causes as it does symptoms. In most cases, it's not a serious ...
Everyday Health on MSN
8 misconceptions and facts about biologics for atopic dermatitis
There are a number of misconceptions about the use of biologic medications for atopic dermatitis. Find out what experts say the facts actually are.
Watch rot' is trending online, but experts warn smartwatch overuse may cause contact dermatitis. Learn the symptoms, causes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results